CNTX - Context Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNTX is currently covered by 1 analysts with an average price target of $5.19. This is a potential upside of $3.17 (156.93%) from yesterday's end of day stock price of $2.02.

Context Therapeutics's activity chart (see below) currently has 1 price targets and 7 ratings on display. The stock rating distribution of CNTX is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Highest price target for CNTX is $5, Lowest price target is $5, average price target is $5.19.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 09-May-2024. First documented stock forecast 02-Feb-2022.

Best performing analysts who are covering CNTX - Context Therapeutics:

Emily Bodnar

Currently out of the existing stock ratings of CNTX, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$3.18 (174.73%)

5

2 months 3 days ago

0/5 (0%)

$3.17 (173.22%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNTX (Context Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on CNTX (Context Therapeutics)?

Emily Bodnar has 3 price targets and 3 ratings on CNTX

Which analyst is the currently most bullish on CNTX (Context Therapeutics)?

Emily Bodnar with highest potential upside - $3.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?